Globus Medical (GMED) EPS (Diluted) Growth (3y) (2014 - 2026)
Globus Medical (GMED) EPS (Diluted) Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 63.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 30.57% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 29.56% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Globus Medical | 10.21 Bn | 9.58 Bn | 525.79 Mn | 23.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.22% |
| Dec 31, 2025 | 56.00% |
| Sep 30, 2025 | 23.39% |
| Jun 30, 2025 | 40.96% |
| Mar 31, 2025 | 13.84% |
| Dec 31, 2024 | 28.41% |
| Sep 30, 2024 | -6.01% |
| Jun 30, 2024 | -16.73% |
| Mar 31, 2024 | -28.45% |
| Dec 31, 2023 | -35.35% |
| Sep 30, 2023 | -73.00% |
| Jun 30, 2023 | 66.95% |
| Mar 31, 2023 | 23.69% |
| Dec 31, 2022 | -17.91% |
| Sep 30, 2022 | 7.62% |
| Jun 30, 2022 | 12.20% |
| Mar 31, 2022 | 3.75% |
| Dec 31, 2021 | 2.93% |
| Sep 30, 2021 | 9.34% |
| Jun 30, 2021 | -3.23% |